Showing results (31-40 of 70) with videos related to
Sort By:
Pageof 7
Oncoimmunology|October 6, 2018
Potentiating cancer vaccine efficacy in liver cancerMaria Tagliamonte, Annacarmen Petrizzo, Angela Mauriello, et al.Cancers|April 30, 2021
Human Endogenous Retrovirus Reactivation: Implications for Cancer ImmunotherapyAnnacarmen Petrizzo, Concetta Ragone, Beatrice Cavalluzzo, et al.Cancer Immunology, Immunotherapy : CII|November 11, 2016
Immunological effects of a novel RNA-based adjuvant in liver cancer patientsLuisa Circelli, Annacarmen Petrizzo, Maria Tagliamonte, et al.Molecular Cancer|April 26, 2023
Molecular mimicry and cancer vaccine developmentMaria Tagliamonte, Beatrice Cavalluzzo, Angela Mauriello, et al.Infectious Agents and Cancer|July 23, 2025
Mandatory preventive vaccines for infectious diseases expressing T-cell epitopes for cancer preventionConcetta Ragone, Angela Mauriello, Beatrice Cavalluzzo, et al.Journal of Translational Medicine|July 14, 2022
Molecular mimicry between tumor associated antigens and microbiota-derived epitopesConcetta Ragone, Carmen Manolio, Angela Mauriello, et al.Molecular Aspects of Medicine|June 9, 2023
Microorganisms-derived antigens for preventive anti-cancer vaccinesLuigi Buonaguro, Beatrice Cavalluzzo, Angela Mauriello, et al.Plos One|August 23, 2012
HIV p24 as scaffold for presenting conformational HIV Env antigensMaria Tagliamonte, Daniela Marasco, Alessia Ruggiero, et al.Cancers|November 24, 2019
High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing ImmunotherapyAngela Mauriello, Roberta Zeuli, Beatrice Cavalluzzo, et al.Journal of Medical Virology|May 7, 2014
Formation of self-assembled triple-layered rotavirus-like particles (tlRLPs) by constitutive co-expression of VP2, VP6, and VP7 in stably transfected high-five insect cell linesZabihollah Shoja, Maria Tagliamonte, Somayeh Jalilvand, et al.Pageof 7